Duexon Pro

Leaflet accompanying the packaging: patient information

Duexon Pro, (50 micrograms + 100 micrograms)/dose, inhalation powder, divided

Duexon Pro, (50 micrograms + 250 micrograms)/dose, inhalation powder, divided

Duexon Pro, (50 micrograms + 500 micrograms)/dose, inhalation powder, divided

Salmeterol + Fluticasone propionate

Read the leaflet carefully before taking the medicine, as it contains important information for the patient.

• Keep this leaflet, so you can read it again if you need to.
• If you have any doubts, consult your doctor, pharmacist, or nurse.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor, pharmacist, or nurse. See section 4.

Table of contents of the leaflet

• 1. What is Duexon Pro and what is it used for
• 2. Important information before taking Duexon Pro
• 3. How to take Duexon Pro
• 4. Possible side effects
• 5. How to store Duexon Pro
• 6. Contents of the packaging and other information

1. What is Duexon Pro and what is it used for

Duexon Pro contains two active substances: salmeterol and fluticasone propionate.

• Salmeterol is a long-acting bronchodilator. Bronchodilators help maintain the patency of the airways. This facilitates the flow of air to and from the lungs. The effect lasts for at least 12 hours.
• Fluticasone propionate is a corticosteroid that reduces swelling and irritation of the lungs.

Duexon Pro is used in the treatment of adults and adolescents from 12 years of age.

The doctor has prescribed this medicine to the patient to prevent breathing disorders that occur in:

• asthma, or
• chronic obstructive pulmonary disease (COPD). Duexon Pro, in a dose of 50 micrograms + 500 micrograms, reduces the number of exacerbations of COPD symptoms.

In order to ensure proper control of asthma or COPD, Duexon Pro must be taken every day as recommended by the doctor.

Duexon Pro prevents shortness of breath and wheezing in the airways. However, it should not be used to control sudden attacks of shortness of breath or wheezing in the airways.

If such an attack occurs, it is necessary to use a rapidly acting bronchodilator, such as salbutamol, immediately. The patient should always carry such a medicine with them.

2. Important information before taking Duexon Pro

When not to take Duexon Pro

• if the patient is allergic to salmeterol, fluticasone propionate, or lactose monohydrate, an excipient of the medicine.

Warnings and precautions

Before starting treatment with Duexon Pro, the patient should discuss with their doctor, pharmacist, or nurse if they have:

• heart disease, including irregular or rapid heartbeat,
• hyperthyroidism,
• high blood pressure,
• diabetes (Duexon Pro may increase blood glucose levels),
• low potassium levels in the blood,
• tuberculosis currently being treated or a history of tuberculosis or other lung infections.

If the patient experiences blurred vision or other vision disturbances, they should contact their doctor.

Children

This medicine should not be used in children under 12 years of age.

Duexon Pro and other medicines

The patient should tell their doctor about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. Duexon Pro should not be used with certain medicines.

Before starting treatment with Duexon Pro, the patient should inform their doctor about taking the following medicines:

• Beta-adrenergic blockers (e.g., atenolol, propranolol, and sotalol). Beta-adrenergic blockers are most commonly used to treat high blood pressure or other heart diseases, such as angina pectoris.
• Medicines used to treat infections (e.g., ketoconazole, itraconazole, and erythromycin), including some medicines used to treat HIV (e.g., ritonavir, cobicistat-containing products). Some of these medicines may increase the levels of fluticasone propionate or salmeterol in the body. This may increase the risk of side effects of Duexon Pro, including irregular heartbeat, or may worsen existing side effects. The doctor may want to closely monitor the patient's condition when taking such medicines.
• Corticosteroids (orally or by injection). If the patient has recently taken such medicines, it may increase the risk of adrenal gland disorders caused by Duexon Pro.
• Diuretics used to treat high blood pressure.
• Other bronchodilators (such as salbutamol).
• Medicines containing xanthine derivatives, such as aminophylline and theophylline, often used to treat asthma.

Pregnancy and breastfeeding

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor before taking this medicine.

Driving and using machines

It is unlikely that Duexon Pro will affect the ability to drive and use machines.

Duexon Pro contains lactose

Each delivered dose of Duexon Pro contains 13 mg of lactose monohydrate. This amount does not cause problems in people with lactose intolerance. The excipient lactose contains small amounts of milk proteins, which may cause allergic reactions.

3. How to take Duexon Pro

This medicine should always be taken as recommended by the doctor. In case of doubts, consult the doctor or pharmacist.

• Duexon Pro should be taken daily until the doctor recommends otherwise. Do not take a higher dose than recommended. In case of doubts, consult the doctor or pharmacist.
• Do not stop taking Duexon Pro or reduce the dose without consulting the doctor.
• Duexon Pro should be inhaled into the lungs through the mouth.

The recommended dose is:

Asthma

Adults and adolescents 12 years and older

• Duexon Pro (50 micrograms + 100 micrograms)/dose: one inhalation twice a day.
• Duexon Pro (50 micrograms + 250 micrograms)/dose: one inhalation twice a day.
• Duexon Pro (50 micrograms + 500 micrograms)/dose: one inhalation twice a day.

Adults with chronic obstructive pulmonary disease (COPD)

• Duexon Pro (50 micrograms + 500 micrograms)/dose: one inhalation twice a day.

If asthma symptoms are well-controlled while taking Duexon Pro twice a day, the doctor may recommend reducing the frequency of taking Duexon Pro to once a day.

• once a day, in the evening, if the patient's symptoms occur at night,
• once a day, in the morning, if the patient's symptoms occur during the day. It is very important that the doctor instructs the patient on how many inhalations and how often to take.

If the patient is taking Duexon Pro for asthma, the doctor will regularly check the symptoms.

In case of worsening asthma symptoms or breathing difficulties, the patient should contact their doctor immediately.

They may experience worsening wheezing, more frequent chest tightness, or may need to use more doses of a rapidly acting inhalation medicine to facilitate breathing. In any of these situations, the patient should continue taking Duexon Pro, but should not increase the number of inhalations. The symptoms of the disease may worsen, and the patient's condition may deteriorate. The patient should contact their doctor, as they may need additional treatment.

Instructions for use

• Duexon Pro may differ from inhalers used by the patient in the past, so it is very important to use it correctly. The doctor, nurse, or pharmacist should train the patient in using the inhaler. This training is important to ensure that the patient receives the required dose. If the patient has not received this training, they should ask their doctor, nurse, or pharmacist to show them how to use the inhaler correctly, especially before the first use.They should also periodically check that the patient is using the inhalation device correctly. Taking Duexon Pro not as recommended by the doctor may cause the medicine not to produce the expected improvement in asthma or COPD.
• The inhalation device contains blisters with salmeterol and fluticasone propionate in powder form.
• The inhalation device is equipped with a dose counter, which indicates how many doses of the medicine are left in the inhalation device. The counter indicates the dose number down to 0. The numbers from 5 to 0 appear in red to warn that there are only a few doses of the medicine left in the inhalation device. If the counter shows 0, it means that the inhalation device is empty.

The patient should not open the mouthpiece cover unless they need to take the medicine, as this will open the blister and the medicine will be wasted.

Using the inhalation device

• 1. To open the inhalation device, the patient should hold the device with one hand in a horizontal position. They should press the red button with their thumb (see Figure 1) and slide the light pink (Duexon Pro (50 micrograms + 100 micrograms)/dose), pink (Duexon Pro (50 micrograms + 250 micrograms)/dose), or light purple (Duexon Pro (50 micrograms + 500 micrograms)/dose) mouthpiece cover away from them – until it clicks (see Figure 2). After performing this action, a small hole appears in the mouthpiece, and the dose of the medicine is placed in the mouthpiece.

Figure 1
Figure 2
Note: Each time the mouthpiece cover is opened after the "click", the blister opens inside, and the next dose of powder is ready for inhalation. Therefore, the patient should not open the mouthpiece cover unless they need to take the medicine, as this will open the blister and the medicine will be wasted.

• 2. The patient should hold the inhalation device at a distance from their mouth and perform a calm, deep exhalation. They should not exhale into the inhalation device.
• 3. The patient should put the mouthpiece into their mouth (see Figure 3). They should take a deep breath from the inhalation device through their mouth, not through their nose. The patient should remove the inhalation device from their mouth. They should hold their breath for about 10 seconds or as long as it is comfortable. Then, they should perform a calm exhalation.

Figure 3
The inhaler delivers a dose of the medicine in the form of a very fine powder. The patient may, but does not have to, feel the powder. The patient should not take an additional dose from the inhaler if they do not feel the taste of the medicine.

• 4. The patient should close the inhaler to keep it clean by sliding the light pink (Duexon Pro (50 micrograms + 100 micrograms)/dose), pink (Duexon Pro (50 micrograms + 250 micrograms)/dose), or light purple (Duexon Pro (50 micrograms + 500 micrograms)/dose) mouthpiece cover back – until it clicks (see Figure 4). The mouthpiece cover has now returned to its original position. The inhaler is now ready for use at the next scheduled dose.
• 5. After inhaling the medicine, the patient should rinse their mouth with water and spit it out and (or) brush their teeth. This may help prevent hoarseness and thrush.

Figure 4

Cleaning the inhaler

The patient should keep the inhaler dry and clean.
In case of need, the patient can wipe the mouthpiece of the inhalation device with a dry cloth or tissue.

Taking a higher dose of Duexon Pro than recommended

It is important to use the inhalation device as recommended. If a higher dose than recommended is taken accidentally, the patient should tell their doctor or pharmacist. The following may occur: faster than normal heartbeat, tremors, dizziness, headache, muscle weakness, and joint pain.
If higher doses are taken for a long time, the patient should contact their doctor or pharmacist for advice, as high doses of Duexon Pro may cause a decrease in the production of steroid hormones by the adrenal glands.

Missing a dose of Duexon Pro

The patient should not take a double dose of the medicine to make up for a missed dose. They should take the next dose at the scheduled time.

Stopping treatment with Duexon Pro

It is very important to take Duexon Pro every day as recommended by the doctor. The patient should take the medicine until the doctor recommends stopping it. The patient should not suddenly stop taking Duexon Pro or reduce the dose, as the symptoms of the disease may worsen.
Additionally, sudden stopping of treatment or reduction of the dose of Duexon Pro may (very rarely) cause adrenal gland disorders (adrenal insufficiency), which can sometimes cause side effects. These side effects may include:

• abdominal pain,
• fatigue and loss of appetite, nausea,
• vomiting and diarrhea,
• weight loss,
• headache and drowsiness,
• low blood sugar,
• low blood pressure and seizures.

When the body is under stress, resulting from fever, injury (such as a car accident), infection, or surgery, adrenal insufficiency may worsen, and any of the above side effects may occur.
If the patient experiences any of these side effects, they should tell their doctor or pharmacist. To prevent these symptoms, the doctor may prescribe additional corticosteroids in the form of tablets (e.g., prednisolone).
In case of any further doubts about taking this medicine, the patient should consult their doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
To minimize the risk of side effects, the doctor will recommend the smallest dose of this medicine that controls asthma or COPD.

Allergic reactions: The patient may experience sudden breathing difficulties immediately after taking Duexon Pro

The patient should stop taking Duexon Proand use a rapidly acting inhalation medicine to facilitate breathing, and contact their doctor immediately. Allergic reactions to Duexon Pro are uncommon (they may occur less often than in 1 in 100 people).

Pneumonia (lung infection) in patients with chronic obstructive pulmonary disease (COPD) (common side effect)

The patient should tell their doctorif they experience any of the following symptoms, which may be signs of a lung infection:

• Fever or chills.
• Increased production of sputum or a change in its color.
• Worsening cough or increased breathing difficulties.

Other side effects:

Very common side effects (may occur more often than in 1 in 10 people)

• Headache - this side effect usually decreases over time with continued treatment.
• Increased frequency of colds in patients with chronic obstructive pulmonary disease (COPD).

Common side effects (may occur less often than in 1 in 10 people)

• Thrush (painful, creamy-yellow patches) in the mouth and throat, as well as tongue pain, hoarseness, and throat irritation. Rinsing the mouth with water and spitting it out and (or) brushing the teeth after each inhalation may be helpful. The doctor may recommend an antifungal medicine to treat thrush.
• Pain, swelling of the joints, and muscle pain.
• Muscle cramps.

The following side effects have been reported in patients with chronic obstructive pulmonary disease (COPD):

• Easier bruising and fractures.
• Sinusitis (feeling of tension and fullness in the nose, cheeks, and behind the eyes, sometimes with a throbbing headache).
• Low potassium levels in the blood (the patient may experience irregular heartbeat, muscle weakness, and cramps).

Uncommon side effects (may occur less often than in 1 in 100 people)

• Increased blood sugar (glucose) levels (hyperglycemia). In patients with diabetes, it may be necessary to monitor blood sugar levels more frequently and adjust the dose of antidiabetic medicines.
• Cataract (clouding of the lens of the eye).
• Very rapid heartbeat (tachycardia).
• Feeling of trembling and rapid or irregular heartbeat (palpitations) - these symptoms usually are not serious and decrease over time with continued treatment.
• Chest pain.
• Anxiety (this side effect occurs mainly in children).
• Sleep disturbances.
• Allergic skin rash.

Rare side effects (may occur less often than in 1 in 1000 people)

• Breathing difficulties or wheezing worsening immediately after taking Duexon Pro. The patient should stop taking Duexon Pro, use a rapidly acting inhalation medicine to facilitate breathing, and contact their doctor immediately.
• Duexon Pro may disrupt the normal production of steroid hormones by the body, especially when taking high doses of the medicine for a long time. These symptoms include:
• slowed growth in children and adolescents,
• decreased bone mass,
• glaucoma,
• weight gain,
• rounding of the face (moon face, Cushing's syndrome). The doctor will regularly check for these side effects and ensure that the patient is taking the smallest dose of this medicine that controls asthma.
• Changes in behavior, such as excessive excitement and irritability (these symptoms occur mainly in children).
• Irregular heartbeat or extra heartbeats (arrhythmias). The patient should inform their doctor, but should not stop taking Duexon Pro unless the doctor recommends it.
• Fungal infection of the esophagus, which can cause difficulty swallowing.

Side effects with unknown frequency (frequency cannot be estimated from available data)

• Depression or aggression (these side effects are more likely to occur in children).
• Blurred vision.

Reporting side effects

If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309,
Website: https://smz.ezdrowie.gov.pl Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.

5. How to store Duexon Pro

• •The medicine should be stored out of sight and reach of children.
• Do not use this medicine after the expiry date stated on the carton and inhaler label after: EXP. The expiry date (EXP) means the last day of the month stated.
• Do not store above 30°C.
• Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Duexon Pro contains

The active substances of the medicine are salmeterol and fluticasone propionate.
Duexon Pro (50 micrograms + 100 micrograms)/dose
Each single inhalation provides a delivered dose (dose leaving the mouthpiece) of 47 micrograms of salmeterol (as salmeterol xinafoate) and 92 micrograms of fluticasone propionate. This is equivalent to a metered dose of 50 micrograms of salmeterol (as salmeterol xinafoate) and 100 micrograms of fluticasone propionate.
Duexon Pro (50 micrograms + 250 micrograms)/dose
Each single inhalation provides a delivered dose (dose leaving the mouthpiece) of 45 micrograms of salmeterol (as salmeterol xinafoate) and 229 micrograms of fluticasone propionate. This is equivalent to a metered dose of 50 micrograms of salmeterol (as salmeterol xinafoate) and 250 micrograms of fluticasone propionate.
Duexon Pro (50 micrograms + 500 micrograms)/dose
Each single inhalation provides a delivered dose (dose leaving the mouthpiece) of 43 micrograms of salmeterol (as salmeterol xinafoate) and 432 micrograms of fluticasone propionate. This is equivalent to a metered dose of 50 micrograms of salmeterol (as salmeterol xinafoate) and 500 micrograms of fluticasone propionate.
The other ingredient is lactose monohydrate (see section 2 under "Duexon Pro contains lactose") (which contains milk proteins).

What Duexon Pro looks like and contents of the pack

• Duexon Pro contains a strip of foil with blisters filled with white or off-white powder. The foil protects the inhalation powder from environmental conditions.
• Each dose is divided.
• The inhalation devices are white with a white mouthpiece and light pink (Duexon Pro (50 micrograms + 100 micrograms)/dose), pink (Duexon Pro (50 micrograms + 250 micrograms)/dose), or purple (Duexon Pro (50 micrograms + 500 micrograms)/dose) mouthpiece covers and are packaged in cartons containing: 1 inhalation device containing 60 inhalations.

Not all pack sizes may be marketed.

Marketing authorization holder

Adamed Pharma S.A.
Pieńków, ul. M. Adamkiewicza 6A
05-152 Czosnów

Importer

Adamed Pharma S.A.
ul. Marszałka Józefa Piłsudskiego 5
95-200 Pabianice
Oy Medfiles Ltd.
Volttikatu 5
70700 Kuopio
Finland
Oy Medfiles Ltd.
Volttikatu 8
70700 Kuopio
Finland
STADA Arzneimittel AG
Stadastrasse 2-18
61118 Bad Vilbel
Germany
STADA Arzneimittel GmbH
Muthgasse 36/2
Wien, 1190
Austria
Clonmel Healthcare Limited
Waterford Road, Clonmel
Tipperary, E91 D768
Ireland
STADA Arzneimittel AG
Stadastr. 2 - 18
61118 Bad Vilbel
Germany

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Austria
Salmeterol/Fluticason STADA 50 Microgram /100 Microgram
single-dose powder for inhalation
Salmeterol/Fluticason STADA 50 Microgram /250 Microgram
single-dose powder for inhalation
Salmeterol/Fluticason STADA 50 Microgram /500 Microgram
single-dose powder for inhalation
France
PROPIONATE DE FLUTICASONE/SALMETEROL EG 100
micrograms/50 micrograms/dose, powder for inhalation in a single-dose container
PROPIONATE DE FLUTICASONE/SALMETEROL EG 250
micrograms/50 micrograms/dose, powder for inhalation in a single-dose container
PROPIONATE DE FLUTICASONE/SALMETEROL EG 500
micrograms/50 micrograms/dose, powder for inhalation in a single-dose container
Germany
Salmeterol/Fluticasonpropionat AL 50 Microgram /100 Microgram
single-dose powder for inhalation
Salmeterol/Fluticasonpropionat AL 50 Microgram /250 Microgram
single-dose powder for inhalation
Salmeterol/Fluticasonpropionat AL 50 Microgram /500 Microgram
single-dose powder for inhalation
Ireland
Sametec Airmaster
Italy
SALMETEROLO E FLUTICASONE EG STADA
Poland
Duexon Pro
Portugal
Inhalok Airmaster 50 micrograms/100 micrograms/dose for inhalation, in a single-dose container
Inhalok Airmaster 50 micrograms/250 micrograms/dose for inhalation, in a single-dose container
Inhalok Airmaster 50 micrograms/500 micrograms/dose for inhalation, in a single-dose container
Inhalok Airmaster 50 micrograms/250 micrograms/inhalation, powder for inhalation (single dose)
Spain
Inhalok Airmaster 50 micrograms/500 micrograms/inhalation, powder for inhalation (single dose)
Sweden
Sipova Airmaster
United Kingdom
Fixkoh Airmaster

Date of last revision of the leaflet: 11/2024